1. Home
  2. AVTX vs LPTH Comparison

AVTX vs LPTH Comparison

Compare AVTX & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • LPTH
  • Stock Information
  • Founded
  • AVTX 2011
  • LPTH 1985
  • Country
  • AVTX United States
  • LPTH United States
  • Employees
  • AVTX N/A
  • LPTH N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • LPTH Semiconductors
  • Sector
  • AVTX Health Care
  • LPTH Technology
  • Exchange
  • AVTX Nasdaq
  • LPTH Nasdaq
  • Market Cap
  • AVTX 88.4M
  • LPTH 81.1M
  • IPO Year
  • AVTX 2015
  • LPTH 1996
  • Fundamental
  • Price
  • AVTX $4.41
  • LPTH $2.02
  • Analyst Decision
  • AVTX Strong Buy
  • LPTH Strong Buy
  • Analyst Count
  • AVTX 7
  • LPTH 3
  • Target Price
  • AVTX $34.33
  • LPTH $4.67
  • AVG Volume (30 Days)
  • AVTX 69.6K
  • LPTH 118.7K
  • Earning Date
  • AVTX 05-12-2025
  • LPTH 05-08-2025
  • Dividend Yield
  • AVTX N/A
  • LPTH N/A
  • EPS Growth
  • AVTX N/A
  • LPTH N/A
  • EPS
  • AVTX N/A
  • LPTH N/A
  • Revenue
  • AVTX $441,000.00
  • LPTH $32,158,517.00
  • Revenue This Year
  • AVTX N/A
  • LPTH $16.90
  • Revenue Next Year
  • AVTX N/A
  • LPTH $52.77
  • P/E Ratio
  • AVTX N/A
  • LPTH N/A
  • Revenue Growth
  • AVTX N/A
  • LPTH N/A
  • 52 Week Low
  • AVTX $4.44
  • LPTH $1.04
  • 52 Week High
  • AVTX $17.49
  • LPTH $4.42
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 29.58
  • LPTH 49.64
  • Support Level
  • AVTX $4.59
  • LPTH $1.61
  • Resistance Level
  • AVTX $5.85
  • LPTH $1.93
  • Average True Range (ATR)
  • AVTX 0.85
  • LPTH 0.19
  • MACD
  • AVTX -0.21
  • LPTH 0.04
  • Stochastic Oscillator
  • AVTX 2.41
  • LPTH 65.08

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.

Share on Social Networks: